We are enclosing herewith unaudited financial results along with limited review for the quarter ended on December 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Raaj Medisafe India Ltd reported strong Q3 FY26 results with revenue from operations rising about 42% year-on-year to Rs. 2,070.68 lakhs (from Rs. 1,458.98 lakhs in Q3 FY25). Net profit grew nearly 85% to Rs. 189.42 lakhs (from Rs. 102.52 lakhs), translating to EPS of Rs. 1.44 versus Rs. 0.76 a year ago. For the nine-month period, revenue climbed around 44.5% to Rs. 5,493.78 lakhs and net profit rose roughly 74% to Rs. 461.65 lakhs (EPS Rs. 3.51 vs Rs. 2.00). The Plastic segment is the larger contributor at Rs. 1,423.44 lakhs in Q3, with Hygiene at Rs. 653.23 lakhs. A point worth noting is that finance costs jumped sharply to Rs. 138.29 lakhs in Q3 from Rs. 51.61 lakhs a year ago, signalling higher borrowing.
Strong double-digit growth in both revenue and profit is a positive signal for shareholders, though the sharp rise in finance costs suggests increased debt and should be monitored closely.